Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

BACKGROUND: To assess the performance of plasma neurofilament light (NfL) and phosphorylated tau 181 (p-tau181) to inform about cerebral Alzheimer’s disease (AD) pathology and predict clinical progression in a memory clinic setting. METHODS: Plasma NfL and p-tau181, along with established cerebrospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Christopher, Lewczuk, Piotr, Kornhuber, Johannes, Richiardi, Jonas, Maréchal, Bénédicte, Karikari, Thomas K., Blennow, Kaj, Zetterberg, Henrik, Popp, Julius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995778/
https://www.ncbi.nlm.nih.gov/pubmed/33766131
http://dx.doi.org/10.1186/s13195-021-00805-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995778/
https://www.ncbi.nlm.nih.gov/pubmed/33766131
http://dx.doi.org/10.1186/s13195-021-00805-8

Ejemplares similares